81 related articles for article (PubMed ID: 1726159)
1. Inhibition of plasminogen activation by monoclonal antibodies to the kringle 5-B chain segment of human plasminogen.
Church WR; Messier TL
Hybridoma; 1991 Dec; 10(6):659-72. PubMed ID: 1726159
[TBL] [Abstract][Full Text] [Related]
2. A battery of monoclonal antibodies that induce unique conformations to evolve cryptic but constitutive functions of plasminogen.
Madoiwa S; Arai K; Ueda Y; Ishizuka M; Mimuro J; Asakura S; Matsuda M; Sakata Y
J Biochem; 1997 Feb; 121(2):278-87. PubMed ID: 9089401
[TBL] [Abstract][Full Text] [Related]
3. Immunochemistry of human Lp[a]: characterization of monoclonal antibodies that cross-react strongly with plasminogen.
Lafferty MA; Salamon AM; Usher DC
J Lipid Res; 1991 Feb; 32(2):277-92. PubMed ID: 1712375
[TBL] [Abstract][Full Text] [Related]
4. Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.
Nihalani D; Raghava GP; Sahni G
Protein Sci; 1997 Jun; 6(6):1284-92. PubMed ID: 9194188
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the streptokinase-catalyzed activation of human plasminogen by human fibrinogen and its plasminolysis products.
Strickland DK; Morris JP; Castellino FJ
Biochemistry; 1982 Feb; 21(4):721-8. PubMed ID: 7200372
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody to the epsilon-aminocaproic acid binding site on the kringle 4 region of human plasminogen that accelerates the activation of Glu1-plasminogen by urokinase.
Cummings HS; Castellino FJ
Arch Biochem Biophys; 1985 Feb; 236(2):612-8. PubMed ID: 2982318
[TBL] [Abstract][Full Text] [Related]
7. [Plasminogen activation by antiplasminogen monoclonal antibody IV-1C. Properties and mechanism of reaction].
Makohonenko IeM; Iakovlev SO; Slomins'kyĭ OIu; Korol'chuk VI; Hrynenko TV; Sokolovs'ka LA; Druzhyna NM; Kolesnykova IM; Chernyshov VI; Sederkhol'm-Vil'iams SA
Ukr Biokhim Zh (1999); 2000; 72(4-5):99-108. PubMed ID: 11200460
[TBL] [Abstract][Full Text] [Related]
8. A kringle-specific monoclonal antibody.
Church WR; Messier TL; Ouellette LA; Potts SE
Hybridoma; 1994 Oct; 13(5):423-9. PubMed ID: 7860098
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivo.
Holvoet P; Lijnen HR; Collen D
J Biol Chem; 1985 Oct; 260(22):12106-11. PubMed ID: 2413020
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of epitopes on human tissue plasminogen activator recognised by a group of monoclonal antibodies.
MacGregor IR; Micklem LR; James K; Pepper DS
Thromb Haemost; 1985 Feb; 53(1):45-50. PubMed ID: 2581330
[TBL] [Abstract][Full Text] [Related]
11. Control of human plasminogen activation.
Castellino FJ; Urano T; de Serrano V; Morris JP; Chibber BA
Haemostasis; 1988; 18 Suppl 1():15-23. PubMed ID: 3127307
[TBL] [Abstract][Full Text] [Related]
12. Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis.
Chaudhary A; Vasudha S; Rajagopal K; Komath SS; Garg N; Yadav M; Mande SC; Sahni G
Protein Sci; 1999 Dec; 8(12):2791-805. PubMed ID: 10631997
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator.
Sim PS; Fayle DR; Doe WF; Stephens RW
Eur J Biochem; 1986 Aug; 158(3):537-42. PubMed ID: 2942403
[TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal antibodies against human tissue plasminogen activator (tPA): quantitation of free tPA in human cell cultures by an ELISA.
Kurokawa T; Toyoda Y; Iwasa S
J Biochem; 1991 Feb; 109(2):217-22. PubMed ID: 1713912
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
López-Alemany R; Longstaff C; Hawley S; Mirshahi M; Fábregas P; Jardí M; Merton E; Miles LA; Félez J
Am J Hematol; 2003 Apr; 72(4):234-42. PubMed ID: 12666133
[TBL] [Abstract][Full Text] [Related]
16. Role of the amino-terminal region of streptokinase in the generation of a fully functional plasminogen activator complex probed with synthetic peptides.
Nihalani D; Kumar R; Rajagopal K; Sahni G
Protein Sci; 1998 Mar; 7(3):637-48. PubMed ID: 9541396
[TBL] [Abstract][Full Text] [Related]
17. Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation.
Zhai P; Wakeham N; Loy JA; Zhang XC
Biochemistry; 2003 Jan; 42(1):114-20. PubMed ID: 12515545
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of urokinase activity and prevention of urokinase receptor binding by monoclonal antibodies.
Zacharias U; Handschack W; Schneider F; Löster K; Kleitke C; Noll F; Will H
J Immunol Methods; 1990 Jun; 130(1):81-90. PubMed ID: 2162894
[TBL] [Abstract][Full Text] [Related]
19. Different effect of 5,6-trans-prostaglandin E2 on plasminogen activation by urokinase and streptokinase.
Urano T; Ikeda C; Shimokawa M; Kinoshita T
Biochim Biophys Acta; 1994 Apr; 1205(2):258-61. PubMed ID: 8155706
[TBL] [Abstract][Full Text] [Related]
20. Activation of human neo-plasminogen-Val442 by urokinase and streptokinase and a kinetic characterization of neoplasmin-Val442.
Powell JR; Castellino FJ
J Biol Chem; 1980 Jun; 255(11):5329-35. PubMed ID: 6445361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
